23-Oct-2026 - Bloomberg Amgen, Astra Drug Duo Boosts Survival for Deadly Lung Cancer Doctors combined powerful medicines from Amgen Inc. and AstraZeneca Plc and found they allowed patients with an aggressive form of lung cancer to live eight months longer.
22-Oct-2026 - Investor's Business Daily At Amgen, sustainability is a companywide commitment Amgen integrates sustainability goals in every part of its business with a holistic and innovative approach to manufacturing.
21-Oct-2026 - The Globe and Mail Piper Sandler Remains a Buy on Amgen (AMGN) Piper Sandler analyst David Amsellem reiterated a Buy rating on Amgen today and set a price target of $457.00. Amsellem covers the Healthcare sector, focusing on stocks such as Amgen, Corcept ...
21-Oct-2026 - Yahoo Finance Amgen (AMGN) Sales Grew 10%, but Can Earnings Catch Up to the Price? Amgen (NASDAQ:AMGN) and AstraZeneca reported Phase 3 results this week for Tezspire in eosinophilic esophagitis, a condition that makes swallowing difficult. The trial met both of its main goals, and ...
21-Oct-2026 - Yahoo Finance What Changed In Amgen's Story? Based on the figures, the new focus looks more reassuring than concerning. Amgen's revenue grew 9.5% from a year earlier in fiscal Q2 2026, and management raised its 2026 revenue guidance to a range ...
Latest AMGN Trades by Congress Members
22-SEP-2026 - David J. Taylor, OH (District 2) purchased between $1,001 and $15,000.
23-Oct-2026 - Bloomberg Amgen, Astra Drug Duo Boosts Survival for Deadly Lung Cancer Doctors combined powerful medicines from Amgen Inc. and AstraZeneca Plc and found they allowed patients with an aggressive form of lung cancer to live eight months longer.
22-Oct-2026 - Investor's Business Daily At Amgen, sustainability is a companywide commitment Amgen integrates sustainability goals in every part of its business with a holistic and innovative approach to manufacturing.
21-Oct-2026 - The Globe and Mail Piper Sandler Remains a Buy on Amgen (AMGN) Piper Sandler analyst David Amsellem reiterated a Buy rating on Amgen today and set a price target of $457.00. Amsellem covers the Healthcare sector, focusing on stocks such as Amgen, Corcept ...
21-Oct-2026 - Yahoo Finance Amgen (AMGN) Sales Grew 10%, but Can Earnings Catch Up to the Price? Amgen (NASDAQ:AMGN) and AstraZeneca reported Phase 3 results this week for Tezspire in eosinophilic esophagitis, a condition that makes swallowing difficult. The trial met both of its main goals, and ...
21-Oct-2026 - Yahoo Finance What Changed In Amgen's Story? Based on the figures, the new focus looks more reassuring than concerning. Amgen's revenue grew 9.5% from a year earlier in fiscal Q2 2026, and management raised its 2026 revenue guidance to a range ...
